← FDA Drug Approvals (Drugs@FDA)

XARELTO

NDA · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2021-12-20

Drug application

FDA Application #

NDA215859

Application type

New Drug Application

Brand name

XARELTO

Generic name

RIVAROXABAN

Active ingredients

RIVAROXABAN

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

JANSSEN PHARMS

Manufacturer

Janssen Pharmaceuticals, Inc.

First approval

2021-12-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown